Notification of persons holding managerial positions and transactions of closely related persons
Notification of persons holding managerial positions and transactions of closely related persons. G. Keliauskas + 370 68718399
Attachment
Advertisement
Recommended Stories
When I Claim My $4,000 Social Security, Will My Wife Automatically Get a Spousal Benefit?
My wife is 76, born in 1948. She retired at full retirement age and currently collects $1,076 per month. I will be retiring and start collecting at 70 this year (I was born in 1954). When I collect $4,000+ per month does her monthly payment go up to spousal benefit automatically or does it have […] The post When I Claim My $4,000 Social Security, Will My Wife Automatically Get a Spousal Benefit? appeared first on SmartReads by SmartAsset.
SmartAssetPalantir raises 2024 forecast on robust AI demand
Data analytics firm Palantir Technologies raised its annual revenue and profit forecast and beat first-quarter sales estimates on Monday, riding on strong demand for its services that help businesses deploy artificial intelligence applications. The company has emerged as a winner of the generative AI boom thanks to its artificial intelligence platform, which is used to test and debug code and help evaluate AI-related scenarios, among other uses. "AIP is driving a huge part of both our new customers and growth within existing customers and its having a huge impact on our business," chief revenue officer Ryan Taylor told Reuters.
ReutersThe Federal Reserve Just Indicated Social Security Could Get a Bigger 2025 Cost-of-Living Adjustment (COLA) Than Expected
A bigger COLA may sound great, but it has some big drawbacks for retirees too.
Motley FoolLucid stock down on Q1 loss, confirms Gravity SUV on track for 'late 2024' launch
EV maker Lucid reported mixed first quarter results as a wider-than-expected loss trumped the company's confirmation that its Gravity SUV is still on track for a 2024 debut.
Yahoo FinanceElon Musk Says Tesla Is Discussing Licensing Self-Driving Technology With "One Major Automaker." Here's Who I Think It Is and Why I See Tesla Stock as the Better Buy.
During Tesla's first-quarter earnings call, investors learned that the company is exploring licensing opportunities in autonomous driving.
Motley Fool$3 trillion could be injected into the U.S. economy without any federal spending by tweaking this corner of the mortgage market, ‘Oracle of Wall Street’ says
"Rarely have I seen such a true win-win scenario for the government, Wall Street and the U.S. consumer."
FortunePalantir Beats Sales Estimates, Raises Outlook on AI Enthusiasm
(Bloomberg) -- Palantir Technologies Inc. beat analysts’ sales estimates in the first quarter and raised its forecast for annual revenue, citing demand from US companies for its new artificial intelligence software.Most Read from BloombergIsrael Rejects a Cease-Fire Plan for Gaza Embraced by HamasAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeEx-Trump Controller Says Cohen Repaid From Personal AccountTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackJack Dorsey Leav
BloombergGrant Cardone Slams Biden's Tax Proposal As 'Another Attempt To Destroy Middle-Class America'
Real estate mogul Grant Cardone took aim at the Biden administration's proposed 25% tax on unrealized gains on taxpayers with wealth greater than $100 million, asking his followers on X to imagine the value of their homes or stocks increasing $400,000. "YOU would owe $25,000 without selling," Cardone posted. "Another attempt to destroy middle-class America." The Budget of the United States Government for fiscal 2025 proposes a new minimum tax on income and unrealized capital gains — for the smal
BenzingaWhy Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
On Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2 PAVIA trial evaluating Duravyu (vorolanib intravitreal insert), previously known as EYP-1901, in patients with non-proliferative diabetic retinopathy (NPDR). The data demonstrated that Duravyu has a biologic effect in patients with NPDR and a favorable safety and tolerability profile; however, the trial did not meet the pre-specified primary endpoint. The company plans to provide an update on the
BenzingaForget Nvidia: Smart Money Is Selling It and Buying These 2 Roaring Artificial Intelligence (AI) Stocks Instead
Nvidia's run at the top of the AI trend may be coming to an end, and smart money is pouring into these 2 AI winners.
Motley Fool